Stay updated on Lanadelumab for Pediatric HAE Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.

Latest updates to the Lanadelumab for Pediatric HAE Attacks Clinical Trial page
- Check6 days agoChange DetectedThe new screenshot shows minor UI and layout updates to the Record History page, with no changes to the recorded version dates or study details, and the underlying history entries and their submission dates appear unchanged; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check34 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference12%

- Check42 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

- Check56 days agoChange DetectedUpdated to Revision: v3.0.2, replacing v3.0.1; removed the 'Back to Top' element.SummaryDifference0.7%

- Check63 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.7%

- Check70 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference20%

Stay in the know with updates to Lanadelumab for Pediatric HAE Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.